The Hypothesis
The labels tell you what to feel.
The cannabis industry has sold the indica/sativa distinction as a reliable predictor of effects for decades.
But controlled research into terpene profiles, cannabinoid ratios, and reported effects suggests the experienced outcome is shaped more by set, setting, tolerance, and expectation than by whether the plant was categorized as indica or sativa.
Blindfold does not claim the distinction has no meaning. It invites you to find out for yourself — without the label telling you what to feel.
The question being tested
In a controlled setting, removed of labels and context, can a cannabis consumer reliably identify which product is indica and which is sativa?
The Methodology
How the trial works.
What You Learn
Your senses reliably detect something real in the product — terpenes, onset characteristics, or some other signal your body can distinguish without visual cues. That's interesting. That's a result.
Your expectation about what you'd feel shaped what you reported feeling. The label was doing more work than the product. That's also a result — and perhaps a more useful one.
Either way
You now know something about yourself that you didn't know before. That's the experiment.
A note on methodology
Blindfold is a self-administered trial, not a peer-reviewed study. Results are personal, not controlled for all variables (dose, tolerance, environment), and should not be interpreted as clinical findings. The value is experiential and informational — helping individual consumers understand their own responses to cannabis products they already use.
For information on the published science behind cannabis effect prediction, terpene research, and the indica/sativa distinction, we recommend reviewing the work of researchers including Dr. Ethan Russo, whose research on cannabis terpenes is foundational to understanding the complexity of cannabis effects.